Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma
A Fard-Esfahani, A Emami-Ardekani… - Nuclear medicine …, 2014 - journals.lww.com
Use of radioactive iodine is an essential adjuvant treatment strategy after thyroidectomy in
patients with differentiated thyroid carcinoma. Although generally safe, radioiodine therapy …
patients with differentiated thyroid carcinoma. Although generally safe, radioiodine therapy …
Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma–a systematic review
SC Clement, RP Peeters, CM Ronckers, TP Links… - Cancer treatment …, 2015 - Elsevier
Background Treatment of differentiated thyroid carcinoma (DTC) often involves
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …
administration of radioactive iodine (I-131) for remnant ablation or adjuvant therapy. As DTC …
Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary …
Background Postoperative radioactive iodine (RAI) administration is widely utilized in
patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to …
patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to …
Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial
Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …
Iodine-131 therapy and nasolacrimal duct obstructions: what we know and what we need to know
MJ Ali - Ophthalmic Plastic & Reconstructive Surgery, 2016 - journals.lww.com
Purpose: The aims of the current review are to summarize the etiopathogenesis,
symptomatology, management, complications, and outcomes of iodine-131-induced …
symptomatology, management, complications, and outcomes of iodine-131-induced …
Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment
B Fallahi, K Adabi, M Majidi… - Clinical nuclear …, 2011 - journals.lww.com
Purpose: Controversies remain over the actual risk of developing a second primary
malignancy (SPM) as a consequence of I-131 treatment in patients with differentiated thyroid …
malignancy (SPM) as a consequence of I-131 treatment in patients with differentiated thyroid …
Iodine-131 therapy and lacrimal drainage system toxicity: nasal localization studies using whole body nuclear scintigraphy and SPECT-CT
MJ Ali, AR Vyakaranam, JE Rao, G Prasad… - Ophthalmic Plastic & …, 2017 - journals.lww.com
Purpose: The objective of this study was to evaluate the influence of dose on nasal
localization of radioactive iodine-131 (I-131) following therapy for differentiated thyroid …
localization of radioactive iodine-131 (I-131) following therapy for differentiated thyroid …
Lacrimal system obstruction after radioiodine therapy in differentiated thyroid carcinomas: a prospective comparative study
FL da Fonseca, PK Yamanaka, JM Kato, S Matayoshi - Thyroid, 2016 - liebertpub.com
Background: Radioiodine therapy (RIT) is an established treatment for differentiated thyroid
carcinomas, and is widely used throughout the world, given the increasing incidence of this …
carcinomas, and is widely used throughout the world, given the increasing incidence of this …
[HTML][HTML] Salivary Dysfunctions and Consequences After Radioiodine Treatment for Thyroid Cancer: Protocol for a Self-Controlled Study (START Study)
C Baudin, C Lussey-Lepoutre… - JMIR research …, 2022 - researchprotocols.org
Background Following radioiodine (131I) therapy of differentiated thyroid cancer, the
salivary glands may become inflamed, leading to dysfunctions and decreases in patients' …
salivary glands may become inflamed, leading to dysfunctions and decreases in patients' …
Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran
During past 3 decades, nuclear medicine has flourished as vibrant and independent
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …